Evidence map›Paper›PMID 37268741›Full record

ReviewNature reviews. Gastroenterology & hepatology2023

Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management.

Heidi M Staudacher, Christopher J Black, Scott B Teasdale, Antonina Mikocka-Walus, Laurie Keefer

Open access · bronzeAbstract readReview
In one paragraph

Review in Nature reviews. Gastroenterology & hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed, 9 pooled it
53.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 9 syntheses or guidelines pooled it, 192 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Effect of Cognitive Behavior Therapy on the Mental Health of Patients With Irritable Bowel Syndrome: A Systematic Review.Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates
    Pooled it
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Low-Molecular-Weight Peptides fromInternational journal of molecular sciences · 2026
    Article
  20. Review

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Heidi M StaudacherFood & Mood Centre, IMPACT Institute, Deakin University Geelong, Melbourne, Victoria, Australia. heidi.staudacher@deakin.edu.au.ORCID 0000-0001-6704-2131
Christopher J BlackLeeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.ORCID 0000-0001-5449-3603
Scott B TeasdalePsychiatry and Mental Health, University of New South Wales, Sydney, New South Wales, Australia.
Antonina Mikocka-WalusSchool of Psychology, Deakin University Geelong, Melbourne, Victoria, Australia.
Laurie KeeferDepartment of Medicine and Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Deakin University · AUIcahn School of Medicine at Mount Sinai · USUniversity of Leeds · GBUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Irritable bowel syndrome (IBS) affects 5-10% of the global population. Up to one-third of people with IBS also experience anxiety or depression. Gastrointestinal and psychological symptoms both drive health-care use in people with IBS, but psychological comorbidity seems to be more important for long-term quality of life. An integrated care approach that addresses gastrointestinal symptoms with nutrition and brain-gut behaviour therapies is considered the gold standard. However, best practice for the treatment of individuals with IBS who have a comorbid psychological condition is unclear. Given the rising prevalence of mental health disorders, discussion of the challenges of implementing therapy for people with IBS and anxiety and depression is critical. In this Review, we draw upon our expertise in gastroenterology, nutrition science and psychology to highlight common challenges that arise when managing patients with IBS and co-occurring anxiety and depression, and provide recommendations for tailoring clinical assessment and treatment. We provide best practice recommendations, including dietary and behavioural interventions that could be applied by non-specialists and clinicians working outside an integrated care model.

Indexed as

Irritable Bowel SyndromeAnxietyComorbidityHumansMental HealthQuality of Life

Identifiers

PMID37268741
PMCPMC10237074
OpenAlexW4379137570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.